Introduction {#Sec1}
============

The ultimate goal in the treatment of rectal cancer is to maximize local control and to improve overall long-term survival. Local recurrence is a serious problem in the treatment of rectal cancer, since it causes disabling symptoms and is difficult to treat; besides, it is thought to be an important factor in overall long-term survival. After conventional surgery, a high incidence of local recurrence of up to 40% was reported \[[@CR1], [@CR2]\]. Heald described a new concept in operative anatomy, the total mesorectal excision (TME) technique in which the entire mesorectum is enveloped and resected \[[@CR3]--[@CR5]\]. The introduction of this surgical technique resulted in a local recurrence rate of \<10% in specialized centers. It was recognized that the involvement of the circumferential margin by tumor cells is predictive for local recurrences \[[@CR6]\]. With this new standardized technique, a unique chance was given to study the effect of (neo)adjuvant therapy. Based on the good results of preoperative radiotherapy in Sweden \[[@CR7]\], the Dutch Colorectal Cancer Group started a randomized multicenter trial. They investigated whether the addition of preoperative radiotherapy increases the benefit of TME \[[@CR8]--[@CR10]\]. The outcome of this study showed a significant reduction in local recurrences with preoperative radiation compared to operation alone in patients with rectal cancer (5.6% versus 10.2% at 6.1 years) \[[@CR11]\]. Differences were not significant for tumors in the upper third of the rectum. Therefore, from the year 2001 onwards, the Comprehensive Cancer Centre Rotterdam decided to standardize preoperative radiotherapy for each patient with a tumor up to 10 cm from the anal verge. A course of 5 × 5 Gy was given to all these patients. However, the TME study was performed in selected patients under optimal conditions and low volume centers still report higher recurrence rates \[[@CR12], [@CR13]\].

This study was designed to assess the outcome after treatment of primary rectal cancer in a community teaching hospital with special emphasis on local recurrence and overall survival.

Materials and methods {#Sec2}
=====================

Patients and preoperative assessment {#Sec3}
------------------------------------

Between 1996 and 2003, the hospital charts of 210 patients with primary rectal cancer were recorded in our prospective database. Medical records were examined to obtain all necessary data. All patients had histologically proven adenocarcinoma of the rectum without evidence of distant metastases at that stage. The inferior margin of the tumor was located not further than 15 cm from the anal verge to be defined as a rectal tumor. Prior to surgery, medical history, physical examination, and routine blood tests were assessed. Work-up consisted of colonoscopy with biopsy, followed by an X-ray of the chest in combination with abdominal ultrasound to exclude distant metastases. In most cases, a computed tomography (CT) scan of the abdomen was also made. In selected cases, especially to rule out the suspicion of invasion of the tumor into adjacent organs, a magnetic resonance imaging (MRI) of the pelvis was made. Our database consists of hospital notes, radiotherapy plans, operation notes, and histopathological reports to obtain the following information: demographics, preoperative diagnostic intervention, tumor staging, radiotherapy technique, surgical details, histopathological details, and complications. Follow-up was registered using hospital notes, medical letters, and in some cases, by general practitioner information.

External beam radiation therapy {#Sec4}
-------------------------------

Starting in 2001, short-term external beam radiation therapy (EBRT) was given to all patients with a tumor up to 10 cm \[[@CR8]\]. A radiation dose of 25 Gy in five daily fractions was delivered. In patients with a locally advanced tumor, 50 Gy radiotherapy was given in 25 daily fractions of 2 Gy. Locally advanced tumor growth was defined as infiltration of the tumor in the environment and/or pathologically enlarged lymph nodes near the circumferential margins of the mesorectum on a CT scan. Afterwards, an evaluation of the effect of radiation therapy was done again by CT scan. When thought feasible, an explorative laparotomy was done with the intention to do a resection. EBRT was administered by a three-field technique, using one posterior and two lateral ports.

Surgery {#Sec5}
-------

All patients underwent surgery according to the TME principle, as advocated by Heald \[[@CR3]\]. In patients with a high rectal cancer, the mesorectum was divided 5 cm below the tumor and a partial mesorectal excision was performed. Surgery was planned 3--5 days after short-term radiotherapy. For locally advanced or T4 tumors, reevaluation was done after irradiation. When feasible, the patient was operated on 5--6 weeks later. Prophylactic intravenous antibiotics were given at the induction of anesthesia in all patients. Three well-trained TME surgeons performed all operations. In case of an anterior resection, a side to end anastomosis was made using the double stapling technique. A diversion stoma was made in case of complicated procedures, a positive leakage test, or incomplete doughnuts. Loop ileostomy was the preferred method in these cases. In case of a positive leakage test, the leakage was localized and sutured when discovered.

Pathology {#Sec6}
---------

The pathologists were trained to identify Circumferential Resection Margin (CRM), positive nodes, and lateral spread of tumor according to the protocol of Quirke et al. \[[@CR14]\].

Adjuvant therapy {#Sec7}
----------------

Generally, patients were not treated with adjuvant chemotherapy, irrespective of nodal status. After 2005, there was a tendency to give adjuvant chemotherapy in well-conditioned patients with positive lymph nodes.

Statistics {#Sec8}
----------

Local control and overall survival curves were calculated from the time of TME and were based on the method of Kaplan and Meier. All statistical analyses were executed in SPSS. Univariate comparisons of survival end points were calculated using the log-rank test. Significance was defined as *P* \< 0.05. For multivariate analysis, Cox regression was used to evaluate prognostic factors.

Results {#Sec9}
=======

Patients {#Sec10}
--------

A total of 210 patients were operated on with curative intent. One hundred thirteen (54%) of the patients were male and 97 (46%) were female with a median age of 70 years (range 40--90 years) The median level of preoperative CEA was 2.8 (range 0.2--142). Preoperative characteristics are shown in Table [1](#Tab1){ref-type="table"}. Fifty-three patients (25%) received preoperative radiotherapy. The majority of these patients (*n* = 42) received short-term radiotherapy. Eleven patients were treated with 50 Gy external beam radiation therapy because of preoperatively defined locally advanced tumors. Since 2001, due to changing policy in preoperative radiotherapy, a growing amount of patients received EBRT. Of the 40 patients (with a tumor below 10 cm) included in this study from 2001, 36 received short-term radiotherapy. Table 1Preoperative characteristics TotalPercentageSymptoms Blood loss15373 Mucus3818 Tenesmus4722 Diarrhea4421 Constipation3517Distance of tumor from anal verge (cm) ≤55928 5--108741 10--156431

Surgical results {#Sec11}
----------------

A low anterior resection (LAR) was done in 145 patients (69%) and an abdominoperineal resection (APR) in 65 patients (31%). Of the 145 patients with a LAR, a diverting stoma was made in 26 patients (18%), which was closed in 18 patients. Five patients underwent a local excision of the tumor (transanal endoscopic microsurgery \[TEM\]) as initial treatment before TME was performed. Thirteen patients (6%) proved to have hepatic metastases during surgery. In ten of these patients, hepatic metastases were not diagnosed by ultrasonography or CT during the preoperative work-up, but discovered during surgery. In the other three patients, liver metastases were calculated and operated on during a second time. The median duration of surgery was 110 min (range 45--210 min) and the median operative blood loss was 600 mL (range 50--4,000 mL). The median blood loss was significantly lower in LAR compared to APR, 400 versus 1,000 mL, respectively (*P* \< 0.001).

Complications are depicted in Table [2](#Tab2){ref-type="table"}. Postoperative mortality was 3% (*n* = 6). Twelve patients underwent a relaparotomy because of abdominal symptoms. During operation, an anastomotic leakage was found in eight patients; three patients were treated with a loop ileostomy and, in five patients, a colostomy was performed after the removal of the anastomosis. A reanastomosis was performed, after 6 and 9 months, in two of these patients. Perineal infections were present in 12 patients (18%) after an APR and treated conservatively. All these 12 patients had been treated with preoperative radiotherapy. Table 2Postoperative complications and reinterventions TotalPercentageMinor complications Urinary infection168 Bladder retention31 Wound infection abdominal178Major complications Wound infection perineal1218^a^ Anastomotic leakage85 Intra-abdominal fluid collection without leak31Reintervention Abscess drainage31 Relaparotomy126 Permanent colostomy73 Permanent ileostomy21 Temporary ileostomy31^a^18% of 65 APRs

Pathology {#Sec12}
---------

In 199 patients (95%), a microscopic complete resection was performed (R0). In 11 (5%) patients, the resection was microscopically incomplete (R1) including four patients with a pT4 tumor. In five patients, incompleteness was related to the distal margin and in six patients because of an incomplete CRM. The postoperative tumor stage is given in Table [3](#Tab3){ref-type="table"}. Two patients had no residual disease after TME. However, these patients had undergone a TEM before TME. TME was performed because the local excision was irradical on pathology. One of these patients had a T1 and one a T2 tumor at the initial pathology. Three patients had a carcinoma in situ. A T1 tumor was seen in 23 patients, a T2 in 63, a T3 in 106, and a T4 tumor in 15 patients. One hundred twenty-eight patients were node-negative, 45 had metastasis in one to three regional lymph nodes (N1), and 37 had metastasis in four or more regional lymph nodes (N2). Table 3Pathology TotalPercentageResidual tumor R019995 R11158AJCC pTNM stage CIS31 I6733 II5325 III7435 IV136

Follow-up {#Sec13}
---------

The median follow-up was 3.6 years (range 0.4--8.4 years). In total, 21 patients developed a local recurrence, most of them (83%) discovered during the first 2 years of follow-up. Fourteen of 199 patients with a complete resection developed a local recurrence (7%). Seven of 11 patients with an incomplete resection developed a local recurrence (64%). A complete resection versus an incomplete resection was of significant importance on local control (*P* \< 0.001; Fig. [1](#Fig1){ref-type="fig"}). The actuarial overall 3- and 5-year local control rates were 92% and 88%, respectively. Nineteen of the local recurrences were found in tumors primary located in the lowest two thirds of the rectum. A high level of CEA (\>5), an APR (Fig. [2](#Fig2){ref-type="fig"}), positive lymph nodes, and an incomplete resection negatively influenced the local recurrence rate significantly. There was no significant difference in age, gender, and preoperative radiotherapy regarding local recurrence (see Table [4](#Tab4){ref-type="table"}). The significant prognostic factors were entered in a multivariate analysis (see Table [5](#Tab5){ref-type="table"}). The most important factor was completeness of the resection. CEA in this multivariate analysis was not of significant importance anymore. Fig. 1Local recurrence according to a complete versus an incomplete resection (*P* \< 0.01)Fig. 2Local recurrence according to type of resection (*P* \< 0.01)Table 4Univariate analysis on 5-year local recurrence-free (LRF) and overall survival (OS) NumberLRF (%)*P* valueOS (%)*P* valueRadiotherapy0.320.17 Yes538267 No1579355Type of resection LAR14593\<0.01610.02 APR656350CEA0.050.04 \<51519065 \>5596548Male114900.55570.60Female968555Age0.36\<0.01 \<801738564 \>80377530Node\<0.010.01 Negative829365 Positive1287934Extent of resection Complete19992\<0.01620.05 Incomplete112017Tumor height (cm)0.110.23 0--5598252 5--10878556 10--15649565Table 5Results of the multivariate Cox regression analysis for local recurrence and overall survival Local recurrenceOverall survivalHR95%CI*P* valueHR95%CI*P* valueType of resection---APR0.200.1--0.50.0000.740.4--1.20.284Lymph nodes---positive3.631.5--8.90.0051.991.2--3.30.007Completeness---incomplete0.000.00--100+0.0001.010.4--2.50.981Level of CEA---\>52.050.8--4.90.1051.831.1--3.00.019Age---\>80------2.761.5--5.00.000*HR* hazard ratio, *95%CI* 95% confidence interval

Distant metastases {#Sec14}
------------------

Forty-five patients developed distant metastases, of which 40% was discovered during the first year of follow-up. Thirty-four patients developed hepatic metastases, 18 lung metastases, and five bone metastases. Lung and/or bone metastases were in 38% synchronic with hepatic metastases.

Overall survival {#Sec15}
----------------

The actuarial overall 3- and 5-year survival rates were 72% and 58%, respectively. The 5-year overall survival demonstrated a statistically significant difference between the pathological TNM (pTNM) stages, type of resection, lymph nodes, CEA levels (Fig. [3](#Fig3){ref-type="fig"}), age, and completeness of the resection (see Table [4](#Tab4){ref-type="table"}). Patient\'s gender and preoperative radiotherapy were not of statistic significance. Increased age, advanced T stage, positive lymph node status, increased CEA, and completeness of the resection were independent risk factors for overall survival in the multivariate analysis (see Table [5](#Tab5){ref-type="table"}). In a Cox regression model, age was the most important factor. Fig. 3Overall survival according to CEA (*P* = 0.04)

Discussion {#Sec16}
==========

Since the introduction of TME as the standard operative technique, the rate of local recurrence after resection of rectal carcinomas spectacularly decreased from 37% in the early 1980s after conventional surgery to \<10% at present \[[@CR5]\]. TME provides sharp meticulous dissection to keep the visceral layer of the pelvic fascia intact and this is important to avoid breach in the mesorectum, which is now an important cause for local recurrence \[[@CR15]--[@CR18]\]. Neoadjuvant radiotherapy demonstrated to improve the TME results with a decreased local recurrence rate, but without an impact on survival \[[@CR11]\]. In the present study, this impact of radiotherapy on local recurrence was not demonstrated, but the number of patients is small.

To define the value of TME in a general hospital population, we decided to include all patients of all ages with a potentially resectable rectal carcinoma. Evaluation of the results, therefore, includes patients previously treated by local transanal resection and patients with postoperatively proven T4 tumors and elderly patients or patients who are not fit enough to enter clinical trials. Bearing this in mind, our results are encouraging. The local recurrence rate was 13% in the whole group at 5 years, including patients with and without preoperative radiotherapy. When considering the microscopically complete resected tumors, the recurrence rate was 9%. R1 resections showed a 21% local recurrence rate, which is similar to what has been described in the literature \[[@CR17], [@CR19]\]. Adequate surgery plays a key role in preventing local recurrences \[[@CR20], [@CR21]\]. Quirke showed a linear correlation between the development of a local recurrence and an inadequate resection with positive circumferential margins \[[@CR14], [@CR22]\]. It is, therefore, of crucial importance to optimize preoperative work-up to identify those patients who will need preoperative treatment in order to downsize and downstage the tumor. In our study, four patients with a local recurrence proved to have T4 tumors, which were not preoperatively correctly diagnosed and, therefore, did not undergo preoperative chemoradiotherapy. New imaging techniques using MRI to stage these tumors accurately will improve this in the future \[[@CR23]--[@CR27]\].

The use of sharp perimesorectal dissection and the practice of "close shave" anterior resection has not only led to fewer recurrences but also increased the sphincter saving rate. Heald et al. \[[@CR28]\] reported that APR was required in 23% of patients with tumors in the lower rectum. In the present study, an APR was performed in 30% of the patients. Since there is a significantly worse outcome on both local control and overall survival and the high rate of perineal complications in patients with an APR pretreated with preoperative radiotherapy, it is favorable to have fewer APR \[[@CR8]\].

Anastomotic leakage is a major complication associated with TME. As the risk of leakage depends on the level of the anastomosis, the incidence of leakage is high following TME in low rectal tumors (7--9%) \[[@CR29]\]. A total of eight patients (5%) in our study developed an anastomotic leakage. Six of them (75%) were located in patients with very low anastomoses (below 5 cm), which increases the risk for leakage. All these patients had been treated with preoperative radiotherapy, which is known to increase the risk for leakage \[[@CR30]--[@CR32]\].

The prognosis in our patient series is similar to other reported data, showing an overall survival of more than 60% after 5 years \[[@CR33], [@CR34]\]. To identify prognostic factors, a univariate analysis was included. As expected, TNM classification was of significant importance for prognosis \[[@CR17]\]. As reported by many others \[[@CR8], [@CR11], [@CR13], [@CR35]--[@CR39]\], completeness of the resection was also a significant prognostic factor. New treatment protocols (neoadjuvant chemoradiation) and meticulous preoperative work-up will possibly lead to more complete resections in the future. Furthermore, in contrast with previous reports \[[@CR40]\], high levels of CEA levels were of significant importance on both overall survival and local recurrence in the present study \[[@CR41]--[@CR44]\]. Age \>80 was also an important factor for a decreased overall survival in the present study. After 5 years, the overall survival of patients above 80 was 30% compared to 64% in patients under the age of 80. The incidence of comorbidity, which renders the patient vulnerable to postoperative complications, is also highest after this age \[[@CR45], [@CR46]\]. After major resectional treatment, elderly patients with rectal cancer have an increased 30-day and 6-month mortality compared with younger patients. Treatment-related mortality is an important competitive risk factor, which obscures the positive effect of modern rectal cancer treatment in those aged 75 years and above \[[@CR37], [@CR46]--[@CR48]\].

In conclusion, TME is a feasible technique with an acceptable rate of postoperative morbidity and low mortality also in a community hospital. Patients with positive lymph nodes, an incomplete resection, aged above 80, and/or a high level of CEA have a poor prognosis. Meticulous preoperative work-up is of great importance to decrease incomplete resections and improve results in future patients.
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